Header

UZH-Logo

Maintenance Infos

Eosinophil-mast cell interaction: Mepolizumab leads to a reduction of clinical symptoms and serum tryptase in a patient with eosinophilic asthma and idiopathic mast cell activation


Guillet, Carole; Steinmann, Simona; Lang, Claudia; Maul, Julia-Tatjana; Schmid-Grendelmeier, Peter (2021). Eosinophil-mast cell interaction: Mepolizumab leads to a reduction of clinical symptoms and serum tryptase in a patient with eosinophilic asthma and idiopathic mast cell activation. The journal of allergy and clinical immunology. In practice, 9(3):1393-1395.e1.

Statistics

Citations

Dimensions.ai Metrics
2 citations in Web of Science®
2 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

1 download since deposited on 08 Jan 2021
0 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Dermatology Clinic
Dewey Decimal Classification:610 Medicine & health
Scopus Subject Areas:Health Sciences > Immunology and Allergy
Uncontrolled Keywords:Immunology and Allergy
Language:English
Date:1 March 2021
Deposited On:08 Jan 2021 16:09
Last Modified:27 Jan 2022 03:59
Publisher:Elsevier
ISSN:2213-2198
OA Status:Closed
Publisher DOI:https://doi.org/10.1016/j.jaip.2020.10.020

Download

Closed Access: Download allowed only for UZH members